Brief: RepliCel's partnership initiatives mature into licensing negotiations
Sept 13 (Reuters) - RepliCel Life Sciences Inc RP.V
* RepliCel Life Sciences Inc - "anticipates maturing
discussions will lead to one or more new partnership agreements
in near-term"
Source text for Eikon: ID:nPnbpyPvfa
Further company coverage: RP.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector